School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Helus Pharma Inc. HELP

Healthcare · Biotechnology

$11.80last close 2026-10-09 · market cap $862.22M · delayed data

Trailing returns

1M-13.74%
3M+77.98%
6M+125.19%
1Y+88.20%
5Y-85.21%

Basis: Adjusted daily closes.

What it does

Helus Pharma Inc., doing business as Helus Pharma, operates as a clinical stage pharmaceutical company that focuses on developing therapies to treat psychiatric and neurological conditions.

Open HELP in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies